Gain Therapeutics, Inc. (GANX) vs Xilio Therapeutics, Inc. (XLO)
- Gain Therapeutics, Inc. GANX 1.26 −5.26%
- Xilio Therapeutics, Inc. XLO 8.77 −2.77%
Gain Therapeutics, Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Xilio Therapeutics, Inc. are of similar size ($59.4M and $58.1M). Xilio Therapeutics, Inc. grew revenue faster over the last twelve months: 327.3% against 18.4%. Gain Therapeutics, Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Xilio Therapeutics, Inc. leads on 10 and Gain Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | GANX | XLO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (48.94%) | 0.00% |
| Net margin | 0.00% | (34.06%) | 0.00% |
| Free cash flow margin | 0.00% | (95.59%) | 0.00% |
| Return on equity | (268.30%) | (55.03%) | (56.36%) |
| Return on assets | (159.22%) | (15.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack